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Purpose: The 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) showed
Nigeria’s progress toward the UNAIDS 90-90-90 targets: 47% of HIV-positive individuals
knew their status; of these, 96% were receiving antiretroviral therapy (ART); and of these,
81% were virally suppressed. To improve identification of HIV-positive individuals, Nigeria
developed an Enhanced Community Case-Finding Package (ECCP). We describe ECCP
implementation in nine states and assess its effect.
Methods: ECCP included four core strategies (small area estimation [SAE] of people living
with HIV [PLHIV], map of HIV-positive patients by residence, HIV risk-screening tool
[HRST], and index testing [IT]) and four supportive strategies (alternative healthcare outlets,
performance-based incentives for field testers, Project Extension for Community Healthcare
Outcomes, and interactive dashboards). ECCP was deployed in nine of 10 states prioritized
for ART scale-up. Weekly program data (October 2019–March 2020) were tracked and
analyzed.
Results: Of the total 774 LGAs in Nigeria, using SAE, 103 (13.3%) high-burden LGAs
were identified, in which 2605 (28.0%) out of 9,294 hotspots were prioritized by mapping
newly identified PLHIV by residential addresses. Over 22 weeks, among 882,449 individuals
screened using HRST, 723,993 (82.0%) were eligible and tested for HIV (state range, 43.7–
90.4%), out of which 20,616 were positive. Through IT, an additional 3,724 PLHIV were
identified. In total, 24,340 PLHIV were identified and 97.4% were linked to life-saving
antiretroviral therapy. The number of newly identified PLHIV increased 17-fold over 22
weeks (week 1: 89; week 22: 1,632). Overall mean HIV positivity rate by state was 3.3%
(range, 1.8–6.4%).
Conclusion: Using ECCP in nine states in Nigeria increased the number of PLHIV in the
community who knew their status, allowing them to access life-saving care and decreasing
the risk of HIV transmission.
Keywords: ART Surge, small area estimation, HIV risk assessment tool, index partner
testing

Introduction
In 2014, the Joint United Nations Programme on AIDS/HIV (UNAIDS) set the 90-90-90
targets for HIV epidemic control by 2020: 90% of people living with HIV (PLHIV) are
aware of their HIV status; of these, 90% are receiving sustained antiretroviral therapy
(ART); and of these, 90% have viral load suppression.1 To determine progress toward the
HIV/AIDS - Research and Palliative Care 2021:13 839–850
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90-90-90 targets and to characterize the HIV epidemic fully,
Nigeria conducted the 2018 Nigeria AIDS Indicator and
Impact Survey (NAIIS), estimating the national HIV preva
lence at 1.3% (95% confidence interval: 1.2–1.4%). NAIIS
results showed higher prevalence in the South-South, SouthEast, and part of North Central geopolitical zones (Figure 1A).
Nigeria's progress toward the UNAIDS 90-90-90 targets was
47-96-81, with approximately 1 million PLHIV yet to be
identified.2 As such, HIV epidemic control is lower than that
reported for some African countries, especially for the first 90
target.3
Progress toward achieving the first 90 target in Nigeria
has faced several challenges, especially in identifying
PLHIV outside of health facilities. Before NAIIS, casefinding was impeded by inadequate epidemiologic data to
guide targeted HIV testing, often leading to misallocation of
testing resources and low case-finding. Without epidemiolo
gic data to guide case-finding efforts, HIV program imple
menting partners used non-targeted testing strategies, such
as general house-to-house testing or testing in places of
worship, markets, and other locations with high volumes
of people but little evidence of HIV burden. Pervasive
security concerns and other logistic and social issues in
Nigeria also hindered effective community testing.
Programs had few rapid test kits, requiring more targeted
testing to optimize use of available resources. With epide
miologic data provided by NAIIS, in April 2019, Nigeria
reshaped programming to control the epidemic more

precisely, scaling up ART programs to provide services to
an additional 500,000 PLHIV within 18 months.4,5 At the
time, resources for case-finding had been reserved for exclu
sive use within healthcare facilities and among key popula
tions. Because of low number of positive individuals
identified, community testing methods had been
discontinued.
The programmatic priority to identify 500,000 PLHIV
required testing beyond healthcare facilities and justified
the needs for redeployment of targeted community casefinding approach to complement facility-level testing.
Testing strategies that improve chances of identifying
HIV-positive cases, such as use of HIV risk assessment
to prioritize whom to test,6 testing sexual partners of
newly-identified HIV-positive cases,7–9 small area estima
tion and hotspots mapping,10,11 were previously described.
However, there were limited studies on the effect of these
strategies on case-finding when used together as
a package. The US President’s Emergency Plan for AIDS
Relief (PEPFAR) Nigeria leveraged these established test
ing strategies and developed an Enhanced Community
Case-Finding Package (ECCP) to accelerate progress
toward the first 90 target. In this paper, we categorized
these four known strategies as core because each of them
was shown to improve chances of identifying HIV-positive
individuals. In addition to the four known core strategies
above, additional strategies that helped PEPFAR Nigeria
to circumvent impediments for successful community HIV

Figure 1 State-level HIV prevalence in Nigeria and the nine states that implemented the enhanced community case-finding package (ECCP) as part of the Nigeria
antiretroviral therapy surge, October 2019–March 2020. (A) Prevalence of HIV by state (NAIIS 2018). (B) Targeted Surge states.
Abbreviations: NAIIS, Nigeria HIV/AIDS Indicator and Impact Survey; FCT, Federal Capital Territory.
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testing services (HTS) were added to the ECCP. The four
additional strategies are: leveraging community-based
organizations (CBOs), incentivizing community testing
teams, remote mentorship in security and hard-to-reach
locations, and use of data to guide decisions. Here, we
describe ECCP implementation and assess community
case-finding during implementation in nine of the 10 tar
geted states.

Methods
Study Design and Ethical Approvals
This was a cross-sectional descriptive study involving
PLHIV identified through routine PEPFAR implemented
HIV program in Nigeria from October 2019 to
March 2020 in nine targeted states. The study was sup
ported by two approved protocols. For results such as
small area estimation pertaining to the Nigeria AIDS
Indicator and Impact Survey (NAIIS), informed consent
was obtained, and the protocol was approved by CDC
IRB, University of Maryland Baltimore IRB, and Nigeria
Health Research Ethics Committee. For procedures and
results pertaining to routine PEPFAR program, deidentified data with no perceived ethical risk to partici
pants were collected, so no informed consent was
obtained. PEPFAR routine program implementation and
ART Surge were reviewed in accordance with CDC
human research protection procedures and were deter
mined to be non-research, public health program activity
and received concurrence from the Government of Nigeria
Federal Ministry of Health. The study fully complies with
the Declaration of Helsinki.

Strategies to Enhance HIV Case-Finding
Using ECCP
ECCP consists of a package of strategies designed to
ensure improved HIV case-finding in communities while
ensuring safety in the face of current security challenges in
Nigeria. The various strategies that were implemented are
described below.

Core Strategies
We categorized the following four strategies as core stra
tegies because each of them is likely to improve the
chances of identifying HIV-positive individuals in
a community to varying degrees independent of the others
as previously described by several studies.6–11
Additionally, the four core strategies targeted either geo
graphical locations or individuals.
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1. Small area estimation (SAE) was used to identify
locations with high treatment coverage gaps. SAE is
a model-based estimation that uses other preexisting survey data, such as NAIIS, and program
data.12 The NAIIS SAE model is similar to the
model used for an earlier geospatial analysis of
HIV prevalence in sub-Saharan Africa.13 NAIIS
provided prevalence estimates at the first subna
tional geographical level (ie, the states in Nigeria),
but estimates for the second subnational geographi
cal level (ie, local government area [LGA]) were
needed for targeted HIV response. There are 774
LGAs in Nigeria across 36 states and the Federal
Capital Territory. SAE helped prioritize LGA-level
testing and resource allocation.
2. After prioritizing LGAs with highest HIV burden
and treatment gap through application of SAE, the
newly identified PLHIV in the prioritized LGA were
mapped by residential address to identify potential
hotspots. For the purpose of the Surge, newly iden
tified PLHIV were defined as individuals who
reported either not knowing their HIV statuses or
reported as known HIV-negative and were tested
positive in the community using HIV rapid diagnos
tic tests. Locations of newly identified PLHIV were
mapped using geocodes of landmarks close to resi
dential addresses. Periodically, locations were
remapped using newly identified PLHIV to identify
additional hotspots for targeted testing.
3. Within identified hotspots, an HIV risk screening
tool (HRST) (Figure 2) was used to assess HIV
infection risk and to increase the likelihood of iden
tifying PLHIV. Testing eligibility requires indivi
duals to answer “yes” to at least one question
assessing HIV risk. Partners of newly identified
PLHIV and HIV key populations were exempted
from screening using HRST. The HRST was devel
oped and tested by Nigeria HIV Prevention Task
Team and included in the package of National HTS
data collection tools.
4. Sexual partners of index cases (newly identified
PLHIV through HRST) were tested to increase like
lihood of identifying additional PLHIV. Each index
client was asked to provide contact information of
sexual partners in the previous year; measures were
taken to ensure confidentiality and to decrease
stigma. To improve confidentiality, counseling was
conducted individually and in a secure location. The
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HIV RISK STRATIFICATION TOOL (age 14 years or older)
Facility Name: ____________________________________ Provider Name: __________________________________________ Date: ____/_____/______
Client Name: _____________________________________________

Sex M

F

Age (years) __________

Introduction: I’m going to ask you some questions to better understand your HIV risk. These can be very personal questions and may be hard to
answer. In order to accurately understand your risk for HIV, I need to ask these questions and I need you to answer them as honestly as possible.
If you need a moment to think before answering that is fine. Whatever we discuss will remain confidential.
Note: When using the tool, if someone reports never having an HIV test remove “since your last HIV test” from the beginning of the question.
Is this HIV test based on a Clinician/Doctor/Health Care Provider’s request?

YES
NO
NEVER
UNKNOWN
POS
NEG
YES
NO

If YES, test for HIV.
If NO, proceed to question 1
If positive, confirm patient is on
ART. If no ART, link to ART
If, NEG, NEVER, or
UNKNOWN,– ask question 2
If YES, test for HIV.
If NO, ask question 3.

YES
NO
YES
NO

If YES, test for HIV.
If NO, ask question 4.
If YES to any of the symptoms,
test for HIV.
If NO, ask question 5.

5. Have you been diagnosed with TB or currently have any of the following symptoms :
cough, fever, weight loss, night sweats?
6. Since your last HIV test, have you ever injected drugs, shared needles or other sharp objects
with someone known to be HIV positive or who you didn’t know their HIV status?
7. Since your last HIV test, have you had anal, oral or vaginal sex in exchange for money or
other benefits?

YES
NO
YES
NO
YES
NO

If YES, test for HIV and TB.
If NO, ask question 6.
If YES, test for HIV.
If NO, ask question 7.
If YES, test for HIV.
If NO, ask question 8.

8. Since your last HIV test, have you been forced to have sex?

YES
NO

If YES, test for HIV and provide
GBV services.
If NO, do NOT test for HIV and
proceed with clinical visit.

1a When was your last HIV test done? _____________
(approximate date of last HIV test in years, months or weeks)
1b. What was the result?
2. Since your last HIV test, have you had anal or vaginal or oral sex without a condom with
someone who was HIV positive or unaware of their HIV status?
3. Since your last HIV test, have you had a blood or blood product transfusion?
4. Since your last HIV test, have you experienced painful urination, lower abdominal pain,
vaginal or penile discharge, pain during sexual intercourse, thick, cloudy, or foul smelling
discharge and/or small bumps or blisters near the mouth, penis, vagina, or anal areas?

ELIGIBLE FOR HIV TESTING?

YES

NO

Figure 2 Nigeria HIV risk stratification (screening) tool (HRST): one of the four core strategies of enhanced community case-finding package (ECCP) deployed as part of the
Nigeria antiretroviral therapy surge, October 2019–March 2020.

state Ministry of Health sent messages via short
message service to identified sexual partners to
invite them to take advantage of free community
health services. Partners of index patients were
tested without HRST screening.

Supportive Strategies
We categorized the following four strategies as suppor
tive because they helped in circumventing obstacles
hindering accesses to a community or might have pro
vided indirect support for optimal implementation of
the four core strategies. The supportive strategies may
be unlikely to contribute substantially in identifying
new PLHIV in the community without at least one of
the four established core strategies. The first three
supportive strategies targeted HTS providers, while
the fourth strategy served as crosscutting intervention
that guided decision making across all other seven
strategies.
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1. Partnering community-based organizations (CBOs)
and alternative healthcare outlets were leveraged to
ensure that testing services are locally adapted and
appropriate. Alternative healthcare outlets, such as
traditional and spiritual healers, traditional birth
attendants, pharmacists, and patent medical ven
dors, serve many Nigerians.14,15 These alternative
healthcare outlets and CBOs were mapped in tar
geted communities, and staff were trained and pro
vided with HIV rapid test kits. PLHIV identified
through CBOs were actively linked to healthcare
facilities for treatment.
2. Performance-based incentives (PBIs) helped engage
field testers. Testing targets were allocated per field
staff or team, and appraisals were conducted every 2
months. A performance-incentive scale was devel
oped such that achieving 50–74%, 75–89%, and
≥90% of assigned monthly testing targets was
rewarded with 30%, 50%, and 100% of monthly
bonus compensation, respectively. Alternative
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healthcare outlets and CBOs were incentivized with
free rapid HIV test kits (at least three test kits) or
cash (between 2–3 US dollars) per identified HIVpositive client.
3. Project Extension for Community Healthcare
Outcomes (ECHO) and peer-to-peer learning
ensured continuous quality improvement of testing
services. Project ECHO is a collaborative model of
medical education and care management that is
operated via remote, low-bandwidth technology to
share and disseminate best practices among
colleagues.16 We leveraged Project ECHO for
weekly virtual mentorship of field testers. Each
state conducted weekly meetings to review perfor
mance and challenges and to replicate best practices
among state teams. Learning exchange visits also
were organized between states.
4. A performance dashboard was used to monitor
trends and provide timely feedback. We deployed
a user-friendly interactive Microsoft Excel dash
board to support program and commodity (test kit
and antiretroviral drugs) tracking. Performance
trends were monitored weekly to develop appropri
ate interventions to improve performance. We con
sidered performance to be good and appropriate
when both the number of newly identified PLHIV
increased (equals or above assigned weekly targets)
and the positivity rate was above state prevalence.

Selection of Implementation States
Using NAIIS data, Nigeria selected six states for priority
interventions given high treatment coverage gaps (categor
ized as red states) and four states that were closer to
epidemic control (categorized as green states). Those
states were Rivers, Akwa-Ibom, and Delta (South-South
zone); Enugu and Imo (South-East zone); Lagos (SouthWest zone); Federal Capital Territory (FCT), Benue, and
Nasarawa (North-Central Zone); and Gombe (North-East
Zone; Figure 1B). Akwa-Ibom was excluded from this
assessment due to lack of access to state data. Despite
high HIV prevalence and treatment gap, Taraba State
was not included because the state was not supported by
PEPFAR. However, following successful implementation
of ECCP in the ten targeted states, Taraba State is now
supported by PEPFAR and added to the ten targeted states.
The estimated HIV treatment gap in nine of the ten tar
geted states was 490,908, about 50% of total HIV treat
ment gap in Nigeria.17 ECCP and ART coverage targets
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constituted the Nigeria ART Surge, and prioritized states
were referred to as Surge states.

Field Implementation Approach
Community testing teams were trained on ethics, the use
of HRST, and index testing of sexual partners. Teams
comprised an HRST administrator, counselor-tester, and
linkage/treatment supporter. Field testers were recruited
from the states where they were deployed, ensuring famil
iarity with the local language and culture. A total of 362
teams were deployed across the nine targeted states, with
Delta and Rivers states having the highest number of
teams (125 and 115 teams, respectively). Testing targets
and terrains determined the number of teams assigned to
each state. Both Rivers and Delta states have higher testing
targets with complex geographical terrains and higher
security threats. Teams operated in the community as
mobile units and prioritized locations where more HIVpositive individuals were identified as guided by mapping
of newly identified PLHIV by residential addresses. To
destigmatize HIV testing, the Surge integrated general
health services (eg, weight check, blood pressure check,
blood sugar, and rapid malaria tests) with community HIV
testing. HIV risk screening using HRST and potential HIV
testing were provided after most other general health ser
vices were received. Participants were general population
in the communities who accepted free general health ser
vices from October 2019 to March 2020. Individuals who
reported not knowing their HIV status or reported an HIVnegative status were eligible for HRST screening.
Individuals who reported an HIV-positive status were
ineligible. Individuals screened-in by HRST underwent
HIV pre-test counseling before rapid HIV testing based
on the national HIV testing algorithm (serial testing with
Determine as the screening test, Unigold as the confirma
tory test, and Stat-Pak as the tiebreaker). Individuals with
HIV-negative test results were counseled on how to mini
mize risk and practice safe sex; those with HIV-positive
test results received post-test counseling and were actively
referred for ART services at the treatment center of their
choice. Additionally, individuals who tested HIV-positive
were provided with a telephone number to call if they need
further counseling, psychosocial support, and support for
partner violence for individuals who consented to partner
notification services (index partner testing) even though all
provided services were strictly confidential.
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Data Collection and Analysis
For mapping of potential hotspots (mapping of HIVpositive individuals by residential addresses), coordinates
of each testing point in the community were captured
using a smartphone Global Positioning System receiver,
and geocodes of major landmarks close to residential
addresses of newly identified PLHIV were documented.
To assess ECCP for each state, daily summaries were
compiled with the following indicators and analyzed
weekly for a period of 22 weeks (October 2019–
March 2020): total number of individuals screened-in
using HRST, number of individuals screened-out using
HRST, total number of individuals tested, total number
of individuals with HIV-positive results, total number of
HIV-positive clients who accepted index partner testing,
total number of partners of index cases elicited, total
number of partners tested, total number of partners tested
positive, HIV positivity rate, and total number of indivi
duals with HIV-positive results who were linked to
treatment.

Results
Over 22 weeks, of the 882,449 individuals screened using
HRST (range per state, 11,105 [Gombe]–557,467
[Rivers]), 723,993 (82%) were eligible and tested for
HIV (range per state, 43.7% [Enugu]–90.4% [Rivers]).
Overall, 158,456 (18%) people were screened-out (not
eligible for testing; screened-out range, 9.6% [Rivers]–
56.3% [Enugu]). Among the 723,993 individuals tested,
69.6% (n=504,149) were from Rivers State (Table 1).
Seven of the nine states implemented community index
testing within the study period; the two remaining states
(Benue and Nasarawa) implemented community index
testing after the study period. Of the total 20,811 PLHIV
identified in the seven states, 3724 (17.9%) were identified
through index testing. Index testing was offered to 13,673
(80.0%) of the 17,087 PLHIV identified through use of
HRST in the 7 states and 11,551 (84.5%) accepted, among
whom 19,506 partners were elicited, for an overall elicita
tion ratio of 1.7:1 (range, 1.3:1 [FCT, Imo, and Enugu]–
2.0:1 [Lagos]). The positivity rate of index testing stream
was 21.4% (range, 15.5 [Imo]–52.1% [Lagos]; Table 1).
Figure 3 summarizes the cascade of results from 7 states
that deployed community index testing during the study
period and hence benefited from full complement of ECCP
core strategies.
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Average positivity rate during the Surge period was
above the positivity rate obtained in the previous five
years among eight of the nine states. There was an
observed decline in positivity rate in Rivers State from
6.1% in 2018 to 3.2% in 2019 (Figure 4A). Similarly,
across all nine states, the volume of newly identified
PLHIV in the community increased 17-fold over 22
weeks (week 1: 89; week 22: 1632). Median increase in
newly identified and initiated PLHIV between the first 11
weeks and second 11 weeks was 41.6% (median: first 11
weeks, 1014; second 11 weeks, 1436). The number of
PLHIV identified increased steadily after week 3, when
mapping of PLHIV by residence was introduced
(Figure 4). The number of CBOs and alternative health
care outlets supported and PBIs were increased in week
12, which also increased the number of PLHIV identified
(Figure 4). Overall, a total of 24,340 PLHIV were identi
fied in the communities using ECCP, of which 23,703
(97.4%) were linked to life-saving ART.

Discussion
Deploying ECCP during the Nigeria ART Surge increased
identification of PLHIV in the communities. Integrating
ECCP core and supportive strategies into normal activities
helped target services to identify PLHIV who did not
know their HIV-positive status. HRST helped to target
testing and to screen-out many individuals without risk
or with low risk of HIV infection, which helped conserve
limited testing resources. Increased positivity rates, which
were above estimated state prevalence in almost all states,
also indicate testing was more targeted. We assumed test
ing as targeted and acceptable when the positivity rate is
higher than state prevalence because prevalence rates esti
mated through population-based household surveys such
as NAIIS were without any testing strategy and were
random results, hence the targeted testing positivity rate
should be above random results if the strategy is effective.
Finally, the absolute number of newly identified PLHIV
increased substantially, and almost all these individuals
were linked to life-saving ART.
Small area estimation was used to target testing in
LGAs with high estimated HIV prevalence. Before
NAIIS, surveys were less precise and provided misleading
estimates. Identifying hotspots for community testing
relied on number of patients receiving treatment in hospi
tals, so LGAs in which these hospitals are located were
targeted for community testing. This approach was inef
fective because most of the time patients tend to access
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Table 1 Results of Enhanced Community Case-Finding (ECCP) Package by Individual Strategy Among the Nine Surge States in Nigeria,
March 2019–October 2020
Rivers
State HIV prevalence (%)

Benue

§

Nasarawa

§

Delta

Gombe

FCT

Imo

Enugu

Lagos

Total

3.6

4.8

1.8

1.7

1.2

1.4

1.7

1.8

1.3

1.3

Estimated state PLHIV (n)

183,029

192,116

66,549

57,895

25,795

57,965

54,021

55,918

126,783

820,071

PLHIV on treatment (n)

26,041

110,878

36,372

15,208

14,377

38,185

12,057

18,110

57,935

329,163

Treatment gap (n)

156,988

81,238

30,177

42,687

11,418

19,780

41,964

37,808

68,848

490,908

Treatment gap (%)

85.8

42.3

45.3

73.7

44.3

34.1

77.7

67.6

54.3

59.9

Total LGAs in the state (n)

23

23

13

25

11

6

27

17

20

165

Targeted LGAs (n)

9

8

11

11

4

4

27

9

20

103

67,003

65,920

26,255

26,081

8970

14,493

54,021

27,272

114,160

404,175

7396

261

472

293

493

75

131

63

110

9294

1734

205

352

121

50

34

46

41

22

2605

23.4

78.5

74.6

41.3

10.1

45.3

35.1

65.1

20.0

28.0

Individuals screened (n)

557,467

63,212

55,237

106,650

11,105

31,778

18,483

22,158

16,359

882,449

Individuals screened-out (test
kits saved) (n)

53,318

28,694

18,487

22,521

4100

12,814

3059

12,473

2990

158,456

Individuals tested (n)

504,149

34,518

36,750

84,129

7005

18,964

15,424

9685

13,369

723,993

% screened-out

9.6

45.4

33.5

21.1

36.9

40.3

16.6

56.3

18.3

18.0

% tested

90.4

54.6

66.5

78.9

63.1

59.7

83.4

43.7

81.7

82.0

13,578

1719

1810

1359

344

763

267

321

455

20,616

2.7

5.0

4.9

1.6

4.9

4.0

1.7

3.3

3.4

2.8

Individuals offered IT (n)

9878

-

-

1359

543

763

267

408

455

13,673

Individuals who accepted IT (n)

8890

-

-

816

343

654

224

321

303

11,551

% accepting IT

90.0

-

-

60.0

63.2

85.7

83.9

78.7

66.6

84.5

Partners elicited (n)

15,380

-

-

1476

469

860

291

420

610

19,506

Partners tested (n)

14,872

-

-

417

376

602

130

388

579

17,364

2885

-

-

132

127

190

20

68

302

3724

1.7

-

-

1.8

1.4

1.3

1.3

1.3

2.0

1.7

Small Area Estimation (SEA):

Estimated PLHIV in targeted
LGAs (n)
Geocode Mapping of New PLHIV
Total hotspots mapped in
targeted LGAs (n)
Hotspots that produced at
least 90% of the positives (n)
Hotspots that produced at
least 90% of the positives (%)
HIV Risk Screening Tool (HRST)

Positive individuals identified (n)
% positive (positivity rate)
Index Partner Testing (IT)

Positive partners identified (n)
Elicitation ratio

(Continued)
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Table 1 (Continued).
Rivers
Testing acceptance among

Benue

§

Nasarawa

§

Delta

Gombe

FCT

Imo

Enugu

Lagos

Total

96.7

-

-

28.3

80.2

70.0

44.7

92.4

94.9

89.0

19.4

-

-

31.7

33.8

31.6

15.4

17.5

52.2

21.4

Total tested (RST and IT) (n)

519,021

34,518

36,750

84,546

7381

19,566

15,554

10,073

13,948

741,357

Total positive (RST and IT) (n)

16,463

1719

1810

1491

471

953

287

389

757

24,340

Positivity rate (RST and IT) (%)

3.2

5.0

4.9

1.8

6.4

4.9

1.8

3.9

5.4

3.3

Community HTS teams (n)

115

20

37

125

13

14

12

20

6

362

Performance appraisal review

2

2

2

2

2

2

2

2

2

18

44

22

22

22

22

22

22

22

22

220

44

22

22

22

22

22

22

22

22

220

elicited partners (%)
IT positivity rate

cycles conducted for field teams
Virtual mentorship sesssions
held (n)
Dashboard review meetings
conducted (n)
Note: §States did not implement IT during the study period.
Abbreviations: LGAs, Local Government Areas; ECCP, Enhanced Community Case-Finding Package; HTS, HIV testing services.

care in hospitals far from their residences due to stigma.18
Mapping newly identified PLHIV by residence narrowed
the geographical area to identify potential hotspots, lead
ing to progressive increases in both positivity rates and
number of newly identified PLHIV, as observed from week
3. The LGA mapping of hotspots, using newly identified
PLHIV, is reported to be an effective way of identifying
hotspots in high-burden areas for targeted testing.19 By
deploying this strategy, only about one-quarter of identi
fied hotspots that produced at least 90% of newly identi
fied PLHIVs were targeted, thereby reducing the potential
number of field testers that would have been spread to over
8000 hotspots, the majority of which are less likely to
produce a substantial number of PLHIV.
Within the hotspots, HRST was used to prioritize test
ing of individuals who were likely to have an HIV-positive
result based on their HIV risk exposures. Because sexual
partners of newly identified PLHIV are likely to be HIVpositive,20 index testing was offered without HRST. In
Malawi, HIV risk screening before rapid test using
a checklist like HRST was found to be very effective.21
Similarly, in Zimbabwe, an HIV-screening tool decreased
the tests needed to identify an HIV-positive individual by
55%.22 In our analysis in Nigeria, HRST resulted in
a saving of about 158,000 rapid diagnostic test kits and
likely contributed to the 3.3% total positivity rate
observed, which is 2.5 times higher than the national
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prevalence of 1.3%. Lower positivity rates in some states
were likely due to sub-optimal application of HRST (eg,
low proportion of screening-out), indicating that low-risk
individuals were inappropriately screened-in for testing.
The huge treatment gaps in Rivers, Imo, and Delta states
likely pushed testers not to use HRST judiciously in des
peration to get more positives, and this was proven by the
observed low proportion of individuals screened-out,
9.6%, 16.6%, and 21.1%, respectively, resulting in low
positivity rates either below or equal to state prevalence.
Lagos also reported a low number of individuals screenedout but with a very high positivity rate of 3.4% compared
to state prevalence of 1.3%. This is because the individuals
screened in Lagos were predominantly key populations
with higher HIV prevalence,23 and key populations were
also exempted from HRST. Similarly, eight of the nine
Surge states demonstrated improvement in positivity rate
when compared with the yield obtained in the previous
five years when Surge was not implemented. Rivers State
demonstrated a decline in positivity rate from 6.1% in
2018 to 3.2% during the Surge period. This decline was
due to the reason highlighted earlier. Index testing is
shown to improve positivity rates and testing
efficiency,7,8 which in this study also improved our
chances of identifying more positive individuals, even
though index clients sometimes were reluctant to provide
information about their sexual partners due to stigma and
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HIV Small Area Estimate
TTtt
(SAE)
Identified subnational
level with greater HIV
burden
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LGAs in Nigeria
n = 774
High burden LGAs
n = 84 (10.9%)

Hotspots mapped
Mapping of newly
identified PLHIV by
residential addresses

n = 8,561
Hotspots prioritized
n = 2,048 (23.9%)

HIV Risk Screening Tool
(HRST) used to screen-in
eligible individuals for
HIV testing

Total individuals
screened

Total individuals
eligible and tested

Individuals tested
HIV Positive

n = 764,000

n = 652,725 (85.4%)

n = 17,087 (2.6%)

Index Partner Testing
(IT) Applied to test
partners of HIV positive
individuals identified.

Total positive
individuals identified
from both streams
(HRST and IT) = 20,811

Individuals offered
IT
n = 13,673 (80.0%)
Partners elicited
Individuals accepting
IT
n = 11,551 (84.5%)

n = 19,506

Partners tested
n =17,364 (89.0%)

Eliciting ratio =1.7:1

Tested positive
n = 3,724 (21.4%)

Figure 3 Cascade of results from implementation of full complement of enhanced community case-finding package (ECCP) in seven of the nine Surge states as part of the
Nigeria antiretroviral therapy surge, October 2019–March 2020.

fear of rejection24 as observed by low overall elicitation
ratio of 1.7:1. The overall positivity rate from the index
testing stream in this study was 21.4%, which implied that
every 1 out of 5 partners tested was positive. This is also
about 17 times higher than national prevalence of 1.3%.
About one-sixth of the new PLHIV identified were identi
fied through the index testing stream. All the seven states
that implemented index testing during the study period
demonstrated improved overall positivity rate when com
pared with HRST positivity rate. Integrated healthcare
approaches, similar to those reported in Uganda,25 were
adapted to destigmatize HIV testing during HRST and
during partner elicitation for index testing, which possibly
improved testing acceptance in the communities. Despite
a modest index testing acceptance rate of 84.5% among
newly identified PLHIV, unfortunately the elicitation ratio
was low. With elicitation ratio of 1:3, we could have
possibly doubled the number of new PLHIV we identified
through the index testing stream, hence this finding

HIV/AIDS - Research and Palliative Care 2021:13

highlighted the need for deploying initiatives to reduce
stigma and other factors contributing to low partner elici
tation among newly identified PLHIV going forward.
A similar study in Kenya reported index testing acceptance
rate of 89% and elicitation ratio of 1:1.3.26
We observed that the four supportive strategies were
particularly important to overcome key programmatic dif
ficulties we faced during community HTS implementation,
such as pervasive security challenges, distrust and suspi
cion whenever community testers were seen in commu
nities, insufficient mentorship, low morale among field
testers, and a culture of low data use to guide decisions
among program implementers. Leveraging alternative
healthcare outlets, such as traditional and spiritual healers,
traditional birth attendants, pharmacists, and patent medi
cal vendors, as well as involvement of community leaders
and influencers,27 helped to provide services safely in
security-challenged areas. These alternative healthcare
outlets, including CBOs, are used by many individuals in
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Figure 4 Community HIV positivity rate trend in nine states that implemented the enhanced community case-finding package (ECCP) as part of the Nigeria antiretroviral
therapy surge. (A) 5-year (2014–2018) positivity rate trend by state versus Surge period (October 2019–March 2020). (B) Weekly positivity rate and number of newly
identified PLHIV by state during the Surge (October 2019–March 2020).
Abbreviations: CBO, community-based organization; PBI, performance-based incentives; wk., week; PLHIV, People Living with HIV.

Nigeria and other developing countries due to religious
beliefs, trust in local alternative healthcare, and lack of
adequate affordable healthcare.14,15,25,28 This approach is
buttressed by previous experience recruiting traditional
birth attendants to support prevention of mother-to-child
HIV transmission as reported in Nigeria and Malawi.29,30
The number of identified PLHIV increased substantially in
week 12, when more CBOs and alternative healthcare
outlets joined the study (Figure 4).
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Project ECHO enabled remote mentorship and support,
especially in locations with major security threats. For exam
ple, in the Rivers State in the Gulf of Guinea, the world’s worst
piracy hotspot with high rates of kidnapping,31,32 CBOs and
community field testers were mentored remotely, and perfor
mance was monitored continuously using Project ECHO. PBIs
is shown to engage field testers and motivate staff, thereby
improving program success and public health outcomes, and
improves commitment and fosters healthy competition among
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public health workers.33,34 The PBI strategy might have influ
enced HTS field testers, which likely resulted in
increased numbers of newly identified PLHIV and treatment
referrals. To ensure individuals were not coerced as a result of
PBIs, we emphasized ethics and volunteerism during training
of community fieldworkers before fieldwork. Additionally, we
ensured strict compliance with national testing guidelines.
Finally, weekly data review, using an interactive Microsoft
Excel dashboard, provided implementers access to data to
drive discussions and rapidly adapt and improve programs.
Without close data monitoring using the dashboard, key pro
grammatic decisions, such as mapping of newly identified
PLHIV by residential addresses, increasing the number of
CBOs, and providing PBIs, would have been missed, decreas
ing our ability to adapt strategies after week 12 to identify more
PLHIV.
There are at least two limitations to our findings. First,
as a programmatic evaluation, we could not quantify the
impact of each strategy independently especially of the
four supportive strategies. Second, we were unable to
determine whether all identified HIV-positive cases are
truly new cases since we relied on self-report awareness;
some PLHIV may have already known their status and
decided to conceal and got re-tested. To minimize this
limitation, we are currently implementing patient bio
metric system among all patients who consented to have
their fingerprints captured and conduct deduplication at
national data repository level.

Conclusion
Overall, implementing ECCP helped identify 24,340
PLHIV from the nine Surge states within 22 weeks and
saved 158,456 test kits. Using our overall positivity rate of
3.3%, the saved 158,456 test kits may identify an addi
tional 5229 PLHIV in the future. Using the combination of
community case-finding strategies in ECCP, including
HIV risk assessment, index testing, small area estimates,
and HIV hotspot mapping, we identified more PLHIV in
the community and linked them to care. Adapting the
strategies presented in this paper and implementing them
as a package may improve HIV case-finding in similar
settings. ECCP can be used by countries with generalized
HIV epidemics and relatively low HIV prevalence to
accelerate HIV case-finding and linkage to care.
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